BI-RADS classification | Isolated DCIS | IDC-DCIS | Isolated-IDC | Isolated ILC | Other tumours | Total | |
---|---|---|---|---|---|---|---|
Diagnostic imaging | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | |
Sonography | 0 | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
1 | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | |
2 | 0 (0%) | 0 (0%) | 0 (%) | 0 (0%) | 1 (11.1%) | 1 (0.8%) | |
3 | 0 (0%) | 0 (0%) | 3 (7.3%) | 0 (0%) | 0 (0%) | 3 (2.5%) | |
4 | 10 (66.7%) | 17 (44.8%) | 10 (24.4%) | 8 (44.4%) | 5 (55.6%) | 50 (41.3%) | |
5 | 5 (33.3%) | 20 (52.6%) | 28 (68.3%) | 10 (55.6%) | 3 (33.3%) | 66 (54.5%) | |
6 | 0 (0%) | 1 (2.6%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (0.8%) | |
Mammography | 0 | 0 (0%) | 1 (2.6%) | 0 (0%) | 1 (5.6%) | 0 (0%) | 2 (1.7%) |
1 | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | |
2 | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | |
3 | 1 (6.7%) | 4 (10.5%) | 3 (7.3%) | 0 (0%) | 1 (11.1%) | 9 (7.4%) | |
4 | 1 (6.7%) | 12 (31.6%) | 17 (41.5%) | 11 (61.1%) | 5 (55.6%) | 46 (38.0%) | |
5 | 13 (86.6%) | 19 (50%) | 17 (41.5) | 6 (33.3%) | 3 (33.3%) | 58 (47.9%) | |
6 | 0 (0%) | 2 (5.3%) | 4 (9.7%) | 0 (0%) | 0 (0%) | 6 (5.0%) | |
MRI | 0 | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
1 | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | |
2 | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | |
3 | 0 (0%) | 0 (0%) | 0 (0%) | 0 (%) | 0 (0%) | 0 (0%) | |
4 | 0 (0%) | 2 (5.3%) | 4 (9.8%) | 0 (0%) | 0 (0%) | 7 (5.8%) | |
5 | 9 (60%) | 22 (57.9%) | 26 (63.4%) | 8 (44.4%) | 3 (33.3%) | 68 (56.2%) | |
6 | 6 (40%) | 14 (36.8%) | 11 (26.8%) | 9 (50%) | 6 (66.7%) | 46 (38.0%) |